Sign up USA
Proactive Investors - Run By Investors For Investors
Market: NYSE
52-week High/Low: $3.92 / $0.98
Sector: Pharmaceuticals
Market Cap: $104.64M


Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.

Deal CUR Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.


Interactive graph

col 3
col 4
col 5
col 6

Neuralstem Timeline

Copyright ©, 2015. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC